Product image of Halcion (Triazolam) supplied by GNH India

Halcion

Active Ingredient:
Triazolam
Origin:
EU

Halcion (Triazolam)

Halcion (triazolam) is an oral benzodiazepine medication used in the European market. It belongs to the sedative‑hypnotic therapeutic class and acts as a positive allosteric modulator of the GABA‑A receptor. The drug is prescribed by healthcare professionals for short‑term management of sleep disturbances and is available only with a prescription.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Halcion is indicated for the short‑term treatment of insomnia, particularly when difficulty falling asleep is the primary complaint. It may be considered in patients who need rapid onset of sleep and have no contraindications to benzodiazepine therapy.

  • Short‑term relief of difficulty initiating sleep
  • Management of transient insomnia associated with stress or jet lag
  • Use in adults when non‑pharmacologic measures are insufficient
  • May be prescribed for occasional sleep disruption in controlled settings
  • Not intended for chronic insomnia without specialist oversight

Side Effects

Side effects of Halcion vary in frequency and severity. Common reactions are usually mild and transient, while serious effects require immediate medical attention.

Common

  • Drowsiness or fatigue
  • Dizziness or light‑headedness
  • Headache
  • Impaired coordination or balance
  • Memory disturbances (anterograde amnesia)
  • Gastrointestinal upset (nausea, constipation)

Serious

  • Respiratory depression
  • Severe allergic reaction (rash, swelling, difficulty breathing)
  • Paradoxical agitation or aggression
  • Dependence or withdrawal symptoms
  • Mood changes (depression, suicidal thoughts)
  • Hallucinations or psychotic symptoms

Precautions & Warnings

Before starting Halcion, several safety considerations should be reviewed to minimize risk. Patients and prescribers should assess the following factors.

  • History of substance abuse, dependence, or withdrawal risk
  • Presence of respiratory disorders such as COPD or sleep apnea
  • Concomitant use of other central nervous system depressants
  • Pregnancy, lactation, or plans to become pregnant
  • Elderly patients who may be more sensitive to sedation and falls
  • Liver or kidney impairment that could affect drug clearance

Avoid Interactions

Halcion can interact with a range of medications, influencing its sedative effect or increasing the risk of adverse outcomes. Interaction categories are outlined below.

Avoid

  • Other benzodiazepines or barbiturates
  • Opioids (e.g., morphine, oxycodone)
  • Alcohol or recreational CNS depressants
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole)

Use with caution

  • Antidepressants (especially SSRIs and SNRIs)
  • Antihistamines and first‑generation antihistamines
  • Anticonvulsants (e.g., carbamazepine)
  • Certain antihypertensives that may enhance hypotension

Frequently Asked Questions

Halcion is primarily prescribed for the short‑term treatment of insomnia, especially when difficulty falling asleep is the main concern.

Triazolam enhances the inhibitory effect of the neurotransmitter GABA by acting as a positive allosteric modulator at the GABA‑A receptor, leading to sedation and reduced neuronal excitability.

Halcion is generally not recommended for pediatric patients; its safety and efficacy have not been established in children and adolescents.

Combining Halcion with alcohol is discouraged because both are central nervous system depressants, which can increase sedation, respiratory depression, and risk of accidents.

Common side effects include drowsiness, dizziness, headache, impaired coordination, memory disturbances, and mild gastrointestinal upset.

Serious reactions such as severe respiratory depression, allergic reactions, paradoxical agitation, dependence, mood changes, or hallucinations should be evaluated by a healthcare professional promptly.

Halcion is intended for short‑term use, typically a few days to a maximum of two weeks, to reduce the risk of tolerance, dependence, and withdrawal.

Elderly individuals may be more sensitive to sedation and falls; dose adjustments and careful monitoring are recommended when prescribing Halcion to this population.

Avoid concurrent use of other benzodiazepines, barbiturates, opioids, alcohol, and strong CYP3A4 inhibitors, as these can increase sedation and respiratory risks.

Yes, prolonged use can lead to physical dependence, and abrupt discontinuation may result in withdrawal symptoms such as anxiety, insomnia, or seizures.

The safety of triazolam during pregnancy has not been established; it should only be used if the potential benefit justifies the potential risk to the fetus.

If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose; do not double the dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Triazolam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT